DecisionRx to offer free PGx testing for Humana PathWays members in Indiana

DecisionRx and Humana Healthy Horizons in Indiana are launching no-cost pharmacogenomic testing and pharmacist-led medication optimization for eligible PathWays for Aging members. The program aims to cut medication failure and avoidable spending for Indiana dual-eligible patients.

Why it matters: - Indiana dual-eligible members in Humana’s PathWays for Aging program will get access to personalized prescribing support at no cost. - The collaboration targets medication failure, a major driver of avoidable spending and adverse drug events in older adults. - DecisionRx cites independent analyses showing more than 30% reductions in annualized healthcare costs per engaged patient.

What happened: - DecisionRx announced a collaboration with Humana Healthy Horizons in Indiana to provide free pharmacogenomic testing and pharmacist-led medication optimization for eligible PathWays for Aging members. - Qualifying members will be invited to complete a one-time PGx test at no cost. - DecisionRx clinical pharmacists will review each member’s PGx results, medication list, claims history and clinical context. - Pharmacists will send personalized prescribing recommendations directly to the member’s prescriber for consideration. - The service is offered at no additional cost to participants.

The details: - Humana’s Fully Integrated Dual Eligible and Medicaid PathWays members in Indiana are eligible for the program. - The process starts with at-home DNA collection kits and enrollment information sent to eligible members. - Participation is voluntary. - DecisionRx pharmacists will develop medication action proposals using a patented medication risk assessment format. - Patients and prescribers will consult through a secure telemedicine platform. - Pharmacogenomic results are expected to remain clinically relevant for the patient’s lifetime and may inform future prescribing decisions across providers. - DecisionRx’s platform combines pharmacogenomic data, pharmacist review and prescription analytics in one workflow. - The system is designed to identify drug-gene interactions, drug-drug contraindications and other opportunities to optimize therapy. - The prescribing physician keeps full clinical authority over any medication changes. - Research cited by DecisionRx says about 40% of prescriptions are ineffective or create new clinical issues. - The same research says medication failure accounts for an estimated 16% of total U.S. healthcare spending. - The company says adverse drug events hit older adults especially hard because many take five or more prescriptions at once. - A Health Affairs Scholar study of more than 15,000 Medicare beneficiaries found the DecisionRx program was associated with a 31.9% reduction in medical spending, equal to $462 PMPM. - Anna Dunn, president of Humana Healthy Horizons in Indiana, said the partnership is meant to make personalized, preventive care part of the PathWays experience. - Travis Morgan, president and co-founder of DecisionRx, said Indiana’s dual-eligible population deserves prescribing guided by genetics and clinical history rather than population averages.

Between the lines: - The partnership fits a broader push toward precision medicine in value-based care. - Humana gets a lower-cost support layer for a high-need population with heavy medication use. - DecisionRx gets a larger real-world channel to show that pharmacist-led medication therapy optimization can reduce spending and improve prescribing quality. - The model shifts part of the prescribing workflow upstream, before drug trial-and-error leads to complications.

What's next: - Eligible members will receive enrollment materials and at-home DNA kits. - DecisionRx pharmacists will begin reviewing results and contacting prescribers after members enroll. - The companies did not provide a start date for member outreach or specify how many Indiana members will be included. - Future prescribing decisions may incorporate the PGx results across providers because the test data remain clinically relevant over time.

The bottom line: - Humana and DecisionRx are pairing free genetic testing with pharmacist review to try to make medication choices safer, faster and less costly for Indiana PathWays members.